Dannielle Appelhans Insider Profile

4 Followers
Dannielle Appelhans, CEO & President at Rubius Therapeutics, holds 20.00K shares in Generation Bio (Ticker: GBIO), holds 0.00 shares in Rubius Therapeutics (Ticker: RUBY). Most recently, Dannielle Appelhans Bought ― shares of Generation Bio on Dec 11, 2023 for an estimated value of 14.34K.
tipranks
Dannielle Appelhans

Dannielle Appelhans
Rubius Therapeutics (RUBY)
CEO & President

Ranked #35,759 out of 99,218 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+28.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$44K
100.00%
A breakdown of Dannielle Appelhans's holdings

Insider Roles

Generation Bio
(GBIO)
Director
Roles that Dannielle Appelhans holds in companies

Most Profitable Insider Trade

Stock:
Generation Bio
(GBIO)
Rating:Informative Buy
Date:Dec 06, 2023 - Today
Return:+33.10%
The most profitable trade made by Dannielle Appelhans

Dannielle Appelhans's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
RUBY
Rubius Therapeutics
Feb 27, 2023
Informative Sell
1.25K
$0.00
Generation Bio
Dec 11, 2023
Director
Informative Buy
14.34K
$44.20K
List of latest transactions for each holding click on a transaction to see Dannielle Appelhans's performance on stock

Dannielle Appelhans insider profile FAQ

What is the percentage of profitable transactions made by Dannielle Appelhans?
The percentage of profitable transactions made by Dannielle Appelhans is 100%.
    What is the average return per transaction made by Dannielle Appelhans?
    The average return per transaction made by Dannielle Appelhans is 28.60%.
      What stocks does Dannielle Appelhans hold?
      Dannielle Appelhans holds: RUBY, GBIO stocks.
        What was Dannielle Appelhans’s latest transaction?
        Dannielle Appelhans latest transaction was an Informative Buy of $14.34K.
          What was Dannielle Appelhans's most profitable transaction?
          Dannielle Appelhans’s most profitable transaction was an Informative Buy of GBIO stock on December 6, 2023. The return on the trade was 33.10%.
            What is Dannielle Appelhans's role in Rubius Therapeutics?
            Dannielle Appelhans's role in Rubius Therapeutics is CEO & President.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.